| Ytd | -72.29% | |
| 1y | -85.19% |
| Open | 0.38 | Prev Close | 0.36 | Low | 0.36 | High | 0.96 | Mkt Cap | 7.33M |
| Vol | 180.98M | Avg Vol | 202.97K | EPS | -1.04 | P/E | N/A | Forward P/E | -8.82 |
| Beta | 0.48 | Short Ratio | 0.70 | Inst. Own | 12.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 09-01 | 50-d Avg | 0.33 | 200-d Avg | 0.82 | 1yr Est | 12.50 |
Gainers Redhill Biopharma (NASDAQ:RDHL) stock increased by 69.4% to $1.12 during Monday's regul
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 100 poi
U.S. stocks traded lower this morning, with the Dow Jones index falling more than 300 points on Mond
LightSolver is pioneering pure photonic computing, bringing a new computing architecture to the publ
Gainers Crinetics Pharmaceuticals (NASDAQ:CRNX) shares moved upwards by 98.7% to $83.53 during Tues
CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetics medicine company developing i
REHOVOT, Israel, June 30, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerat
From mining to biotech, these companies are exploring strategic alternatives, including a sale, to u
COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.21) per share which missed
REHOVOT, Israel, May 29, 2026 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerati
REHOVOT, Israel, April 13, 2026 /PRNewswire/ -- CollPlant (NASDAQ: CLGN), a regenerative and aesthe
Inhibrx Biosciences (NASDAQ: INBX - Get Free Report) and CollPlant Biotechnologies (NASDAQ: CLGN - G
CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.25) per share which missed
CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.25) per share which missed
REHOVOT, Israel, March 26, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenera
CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetic medicine company developing in
REHOVOT, Israel, March 24, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenera
REHOVOT, Israel, March 18, 2026 /PRNewswire/ -- CollPlant (Nasdaq: CLGN), a regenerative and aesthet
CollPlant Biotechnologies (NASDAQ: CLGN - Get Free Report) and CG Oncology (NASDAQ: CGON - Get Free
REHOVOT, Israel, March 11, 2026 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenera
Intellectual Property Rights Secured in One of the Largest Target Markets for CollPlant's Product
BioFlex Enables Rapid Formulation of Tunable rhCollagen Bioinks with Enhanced Tissue-Mimetic Perform
Next-generation rhCollagen-based technology aims to restore facial structure and skin quality in pat
REHOVOT, Israel, Feb. 5, 2026 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN), a regenerati
Expansion of rhCollagen and BioInk raw material sales in North American territories expected through
REHOVOT, Israel , Nov. 18, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenera
TuHURA Biosciences (NASDAQ: HURA - Get Free Report) and CollPlant Biotechnologies (NASDAQ: CLGN - Ge
-- New North American logistics center will provide expanded distribution for CollPlant's rhCollagen
A head-to-head study by Israel's Technion found that CollPlant's rhCollagen-based bioink, Collink.3D